共 115 条
[1]
Singer M(2016)The third international consensus definitions for Sepsis and septic shock (Sepsis-3) Jama 315 801-810
[2]
Deutschman CS(2013)Severe sepsis and septic shock N Engl J Med 369 840-851
[3]
Seymour CW(2004)Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J Thromb Haemost 2 1924-1933
[4]
Angus DC(2016)Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan Crit Care 20 229-261
[5]
van der Poll T(2016)Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan Int J Hematol 103 253-1166
[6]
Dhainaut JF(2016)Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study Thromb Haemost 115 1157-1479
[7]
Yan SB(2014)Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study J Thromb Haemost 12 1470-1019
[8]
Joyce DE(2014)Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan J Thromb Haemost 12 1010-89
[9]
Yamakawa K(2018)The Japanese clinical practice guidelines for Management of Sepsis and Septic Shock 2016 Acute Med Surg 5 3-858
[10]
Umemura Y(2001)Identification of novel genes coding for small expressed RNAs Science 294 853-10518